中国卒中学会急性缺血性卒中再灌注治疗指南2024 Chinese Stroke Association Guidelines on Reperfusion Therapy for Acute Ischemic Stroke 2024

Abstract

近年来，急性缺血性卒中静脉溶栓和机械取栓领域的临床试验取得了显著进展，新的研究结果不断扩大静脉溶栓和机械取栓的适应证人群。基于研究进展，中国卒中学会急性缺血性卒中再灌注治疗指南2024编写组邀请我国卒中领域的专家，对现有的急性缺血性卒中再灌注治疗证据进行广泛讨论，形成了分级推荐意见。本次指南制定对静脉溶栓和机械取栓治疗的最新筛选标准进行了概述，并汇总了不同溶栓药物选择的现有证据，以期对急性缺血性卒中的再灌注治疗决策提供帮助。 Abstract: Recently, significant progress has been made in clinical trials in the field of intravenous thrombolysis and mechanical thrombectomy for acute ischemic stroke. New research results continuously expanded the indications for both intravenous thrombolysis and mechanical thrombectomy. Based on these advancements, the Writing Group of Chinese Stroke Association Guidelines on Reperfusion Therapy for Acute Ischemic Stroke 2024 invited experts in the field of stroke in China to extensively discuss the existing evidence on reperfusion therapy for acute ischemic stroke, resulting in graded recommendations. This guideline outlines the latest screening criteria for intravenous thrombolysis and mechanical thrombectomy and summarizes the current evidence on different thrombolytic drug options, in order to provide a reference for decision-making on reperfusion therapy of acute ischemic stroke.

Keywords

• 缺血性卒中
• 脑血管病
• 再灌注治疗
• 机械取栓
• 血管内治疗
• 静脉溶栓
• ischemic stroke
• cerebrovascular disease
• reperfusion therapy
• mechanical thrombectomy
• endovascular treatment
• intravenous thrombolysis